Prosecution Insights
Last updated: July 17, 2026

Nanobiotix S A

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Portfolio Summary

3
Total Pending OAs
1
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
3
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only3 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
67% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
33% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KALIHER, HANS CHRISTIAN 1 61.8% +29.6%
BECKHARDT, LYNDSEY MARIE 1 27.9% +48.2%
GREENE, IVAN A 1 18.7% +6.2%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18035303 COMPOSITIONS OF NANOPARTICLES FOR TREATMENT OF CANCER BECKHARDT, LYNDSEY MARIE
17927372 NANOPARTICLES, IONIZING RADIATION AND INNOVATIVE THERAPEUTIC COMBINATIONS THEREOF GREENE, IVAN A

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18039728 POROUS, HIGH-Z AND CARBON-FREE PARTICLES AS RADIOENHANCERS KALIHER, HANS CHRISTIAN
18035303 COMPOSITIONS OF NANOPARTICLES FOR TREATMENT OF CANCER BECKHARDT, LYNDSEY MARIE

Top Art Units

Art UnitApps
3781 1
1613 1
1619 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18039728 POROUS, HIGH-Z AND CARBON-FREE PARTICLES AS RADIOENHANCERS KALIHER, HANS CHRISTIAN 3781 §103 Final Rejection Pending Jun 01, 2023
18035303 COMPOSITIONS OF NANOPARTICLES FOR TREATMENT OF CANCER BECKHARDT, LYNDSEY MARIE 1613 §103 Non-Final OA Pending May 04, 2023
17927372 NANOPARTICLES, IONIZING RADIATION AND INNOVATIVE THERAPEUTIC COMBINATIONS THEREOF GREENE, IVAN A 1619 §103 Final Rejection Pending Nov 23, 2022

Managing Nanobiotix S A's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month